These provisions for “second medical use” also rely on the claims for use in a method of treatment being interpreted to include the physiological or technical effect of the treatment as being a functional feature of the claim. However, the interpretation...
However, in a significant development we now report, means-plus-function language for a claim to an antibody complied with both of the USPTO requirements for written description and for the claim not to be indefinite. Where functional language alone is used in US...
Registered Design Rights be they UK Registered Design Rights, European Registered Design Rights, US Design Patents or Registered Design Rights granted in other jurisdictions are highly useful Intellectual Property Rights that have been increasing in commercial...
Background In our article of January 2024, we reported that the opponent in the case underpinning the “plausibility” referral (G 2/21) had filed a petition for review of the referring board’s decision (T 116/18) by the Enlarged Board of Appeal. That petition is...
When the European Union’s new Unified Patent Court (“UPC”) opened for business in June last year, its jurisdiction only extended to 17 of the 27 EU Member States. A further 7 Member States committed to joining at a later date, with Croatia, Spain, and Poland opting...
On 24 April 2024, in case UPC_CFI_316/2023, the UPC’s Paris Central Division granted Nicoventures Trading Limited access to written pleadings and evidence in a patent revocation case brought by NJOY Netherlands B.V. against Juul Labs International, Inc concerning...
Recent Comments